“If enacted across the board, Trump’s order would mean pharmaceutical companies must sell drugs to Americans at the lowest prices they were offering anybody else in the world.”
…
“Americans do pay significantly more for prescription drugs than people in other developed nations, but the reasons for that are more complicated than Trump suggests.
“There are many good reasons why we should pay more for earlier access to new medications than our trading partners,” wrote Darius Lakdawalla and Dana Goldman of the University of Southern California’s Schaeffer Institute for Public Policy & Government Service. “As the world’s largest market for pharmaceuticals, America finds itself in the unique position of accruing the lion’s share of the benefits from new medicines. We often recoup these additional costs in the form of longer and healthier lives.””
…
“”facing a choice between deep cuts in their U.S. pricing or the loss of weakly profitable overseas markets,” the companies may simply exit foreign markets altogether, “leaving U.S. consumers with the same prices, pharmaceutical manufacturers with lower profits, and future generations with less innovation.””